Skip to main content
. 2019 Jan 28;5(2):277–289. doi: 10.1021/acscentsci.8b00688

Figure 12.

Figure 12

F-DMA/CCL19 increased CCL19, IFN-γ and TNF-α expression in peritoneal colon cancer model. Peritoneal fluid, tumor tissue and serum of the five groups (GS, F-DMA, F-DMA/pVax, DMA/CCL19, and F-DMA/CCL19) were collected after two doses, and we measured the expression of CCL19, IFN-γ and TNF-α by ELISA in the peritoneal fluid (A), tumor tissue protein (B), and serum (C). Mean ± SEM, n = 5; *p < 0.05, **p < 0.01 when compared with GS-treated group. The results represent three independent experiments.